This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Human Embryonic Stem Cells (JNJ)

Johnson & Johnson

Drug Names(s): hESCs

Description: In vivo, human embryonic stem cells (hESCs) have been shown to develop into mature pancreatic endocrine cells, supporting the use of hESCs as an alternative to cadaveric islets for treating diabetes.


Human Embryonic Stem Cells (JNJ) News

Pink Sheet Stem Cell Research

Pink Sheet Stem Cell Patents

Pink Sheet Stem Cell Research


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug